Expressão dos receptores FC de imunoglobulina A em fagócitos do sangue de pacientes com bacteremia. / Expression of immunoglobulin a FC receptors on blood phagocytes of patients with gram-negative bacteremia.
AUTOR(ES)
Murilo Chiamolera
DATA DE PUBLICAÇÃO
2001
RESUMO
The expression and function of FcaRI (CD89) were analyzed on blood monocytes and neutrophils of patients with gram-positive and gram-negative bacteremia. Eighteen patients with gram-positive bacteremia, sixteen patients with gram-negative bacteremia and twenty healthy individuals were studied. CD89 expression were analyzed by flow cytometry using specific stained antibodies. Analysis of the surface iodinated CD89 molecules by SDS-PAGE and of the CD89 g-associated chain by immunoblotting also were performed. A marked increase in expression of the a and g subunits of the FcaRI were found on both types of cells in patients with gram-negative bacteremia, but not in patients with gram-positive bacteremia. This increase was independent of serum IgA levels. FcaRI Mr was lower on cells from gram negative patients than on cells from controls (50-65 kDa vs 55-75 kDa) despite of similar 32 kDa backbone, indicating altered glycosylation. Increased levels of FcaRI on blood phagocytes correlated with enhanced serum IL-6 levels, but not with IFN-g or TNF-a levels. The CD89 g-associated chain was phosphorylated on neutrophils, suggesting an engagement of CD89 during gram negative sepsis.
ASSUNTO(S)
bacteremia/imunologia receptores fc/análise imonoglobulinas/análise fagócitos/imunologia sepsis citometeria de fluxo/métodos iga fc receptor iga/análise
Documentos Relacionados
- Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: a meta-analysis.
- Monotherapy versus beta-lactam-aminoglycoside combination therapy for gram-negative bacteremia.
- Gentamicin and gram-negative bacteremia. A synergism for the development of experimental nephrotoxic acute renal failure.
- Receptors for human plasminogen on gram-negative bacteria.
- Antibody response of patients with malignancies to bacteremia with gram-negative bacteria.